Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9498485
SERIAL NO

14839820

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LIPOCINE INC675 ARAPEEN DRIVE SUITE 202 SALT LAKE CITY UT 84108

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chidambaram, Nachiappan Sandy, US 142 950
Frank, Joel Sandy, US 24 107
Nachaegari, Satish Kumar Salt Lake City, US 47 640
Patel, Mahesh V Salt Lake City, US 184 9603
Venkateshwaran, Srinivasan Salt Lake City, US 89 3350

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 22, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00